• Kymera Therapeutics' (KYMR) "Buy" Rating Reiterated at Truist Financial

    Источник: Buzz FX / 01 ноя 2024 11:02:16   America/Chicago


    Kymera Therapeutics' (KYMR) "Buy" Rating Reiterated at Truist Financial Written by MarketBeat November 1, 2024 Share Link copied to clipboard. Kymera Therapeutics ( NASDAQ:KYMR - Get Free Report ) 's stock had its "buy" rating reiterated by
    Read more...
Опубликовать